Chief Healthcare Executive October 9, 2024
The devices have become more widely used to help patients manage diabetes. Ash Shehata of KPMG talks about his optimism for the market.
As KPMG’s U.S. sector leader for healthcare, Ash Shehata has been tracking the market for continuous glucose monitors for years.
He’s optimistic that the market is going to grow significantly in the coming years.
“We love the market,” Shehata tells Chief Healthcare Executive®.
“We talk about modernizing health tech. It’s probably one of the best examples that so many people can get to,” he says.
Continuous glucose monitors help patients with diabetes track their blood sugar levels easily. A small device is implanted in the patient’s skin, often under the arm, and patients can see their blood...